The effect of catalyst on the yield of amine in the amination of three classes of arylzinc reagents with acetone oxime O-tosylate was investigated. Since they allowed the preparation of arylamines in excellent yields in the presence of a minimum amount of copper (I) or copper (II) compounds, the catalytic systems using copper (I) or copper (II) combined with a P-, N-or S-donor ligand were revealed to be the best catalysts for the electrophilic amination of arylzinc reagents with acetone oxime O-tosylate in the presence of DMPU.
Amines Q 0120Cosolvent-Promoted Electrophilic Amination of Organozinc Reagents. -By use of a cosolvent, the amount of CuCN and waste is reduced and the yields are improved.-(DASKAPAN*, T.; YESILBAG, F.; KOCA, S.; Appl. Organomet. Chem. 23 (2009) 6, 213-218; Fac. Sci., Ankara Univ., TR-06100 Ankara, Turk.; Eng.) -Bartels 41-061
In this study, we aimed to develop a simple and efficient method for the electrophilic amination of organozinc reagents. For this reason, 12 cosolvents were screened in the electrophilic amination of ordinary organozinc reagents. By the use of a cosolvent, an easily applicable and high-yielding method for the preparation of arylamines by electrophilic amination of arylzinc reagents was developed.
agents. -The amination of three classes of arylzinc reagents with acetone oxime O-tosylate is accomplished in the presence of a copper(I) or copper(II) catalyst and DMPU. P-, N-, or S-ligands have an accelerating effect on the reaction and cause in many cases a significant reduction of the amount of copper catalyst needed. -(DASKAPAN*, T.; KOCA, S.; Appl.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.